Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with metastatic castration-sensitive prostate cancer and hrr alterations
CA3280564A1Pending Publication Date: 2026-09-21JANSSEN PHARMA NV
0 Cites 0 Cited by
Patent Information
- Application Number
- CA3280564
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-03-05
- Filing Date
- 2025-07-21
- Publication Date
- 2026-09-21
Need to check novelty before this filing date? Find Prior Art
No text content released.